Patents, trademarks and designs in M&A transactions - strategies and challenges

Many small and medium-sized companies often lack sufficient awareness of the potential and challenges involved in dealing with intellectual property. Intellectual property (IP) can not only make a significant contribution to a company's own value creation, but can also help to bring together different values in upcoming M&A transactions. In the pharmaceutical and life science industries in particular, a patent strategy tailored to industry-specific requirements is essential - especially in view of the lengthy development cycles. Reason enough for the 30th Munich M&A Forum to take an in-depth look at the topic of patents, trademarks and designs in M&A transactions.